Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol. 2012;18(2):195-202.   Published online 2012 Jun 26     DOI:
Citations to this article as recorded by Crossref logo
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim
Digestive Diseases and Sciences.2018; 63(10): 2792.     CrossRef
Hepatitis B virus infection and alcohol consumption
Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada
World Journal of Gastroenterology.2017; 23(15): 2651.     CrossRef
Emerging concepts in alcoholic hepatitis
Phoenix Fung, Nikolaos Pyrsopoulos
World Journal of Hepatology.2017; 9(12): 567.     CrossRef
Interaction of obesity and infections
N. V. Dhurandhar, D. Bailey, D. Thomas
Obesity Reviews.2015; 16(12): 1017.     CrossRef
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B
J. C. Hsiang, G. L.-H. Wong, H. L.-Y. Chan, A. W.-H. Chan, A. M.-L. Chim, V. W.-S. Wong
Alimentary Pharmacology & Therapeutics.2014; 40(6): 716.     CrossRef